Molinari C.; Medri L.; Follo M.Y.; Piazzi M.; Mariani G.A.; Calistri D.; Cocco L., PI-PLCβ1 gene copy number alterations in breast cancer, «ONCOLOGY REPORTS», 2012, 27, pp. 403 - 408 [articolo]
C Filì; M Follo; G Martinelli; I Iacobucci; F Cattina; C Skert; C Bergonzi; M Malagola; C Finelli; M Gobbi; A Candoni; F Lauria; F Lanza; A Turra; R Ribolla; V Cancelli; L Cocco; D Russo, PROSPECTIVE PHASE II STUDY ON LOW-DOSE 5-AZACYTIDINE FOR TREATMENT OF SYMPTOMATIC PATIENTS WITH LOW/INT-1 RISK MYELODISPLASIA, in: Abstract Book, «HAEMATOLOGICA», 2012, 97, pp. 129 - 129 (atti di: 17th Congress of the European Hematology Association, Amsterdam, The Netherlands, June 14 – 17, 2012) [atti di convegno-abstract]
J.A. McCubrey; L.S. Steelman; W.H. Chappell; S.L. Abrams; R.A. Franklin; G. Montalto; M. Cervello; M. Libra; S. Candido; G. Malaponte; M.C. Mazzarino; P. Fagone; F. Nicoletti; J. Bäsecke; S. Mijatovic; D.Maksimovic-Ivanic; M. Milella; A. Tafuri; F. Chiarini; C. Evangelisti; L. Cocco; A.M. Martelli., Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance., «ONCOTARGET», 2012, 3, pp. 1068 - 1111 [articolo]
Follo MY; Faenza I; Fiume R; Ramazzotti G; McCubrey JA; Martelli AM; Manzoli FA; Cocco L, Revisiting nuclear phospholipase C signalling in MDS, «ADVANCES IN BIOLOGICAL REGULATION», 2012, 52, pp. 2 - 6 [articolo]
Follo MY; Mongiorgi S; Clissa C; Baccarani M; Paolini S; Curti A;
Papayannidis C; Martinelli G; Manzoli L; Finelli C; Cocco L, ROLE OF INOSITIDE-DEPENDENT SIGNAL TRANSDUCTION PATHWAYS ON EPO-INDUCED EYTHROID DIFFERENTIATION IN LOW-RISK MDS PATIENTS, in: HAEMATOLOGICA, 2012, 97, pp. S37 - S37 (atti di: XII Congress of the Italian Society of Experimental Hematology, ROMA, 17-19 OTTOBRE 2012) [Contributo in Atti di convegno]
J. A. McCubrey; L.S. Steelman; S.L. Abrams; N. Misaghian; W.H. Chappell1; J. Bäsecke; F. Nicoletti; M. Libra; G. Ligresti; F. Stivala; D. Maksimovic-Ivanic; S. Mijatovic; G. Montalto; M. Cervello; P. Laidler; A. Bonati; C. Evangelisti; L. Cocco; A.M. Martelli., Targeting the cancer initiating cell: the ultimate target for cancer therapy., «CURRENT PHARMACEUTICAL DESIGN», 2012, 18, pp. 1784 - 1795 [articolo]
A.M. Martelli; G. Tabellini; D. Bressanin; A. Ognibene; K. Goto; L. Cocco; C. Evangelisti., The emerging multiple roles of nuclear Akt., «BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH», 2012, 1823, pp. 2168 - 2178 [articolo]
Ruolo editoriale nella rivista «Advances in Enzyme Regulation»
Cenni V; Bavelloni A; Beretti F; Tagliavini F; Manzoli L; Lattanzi G; Maraldi NM; Cocco L; Marmiroli S;, Ankrd2/ARPP is a novel Akt2 specific substrate and regulates myogenic differentiation upon cellular exposure to H(2)O(2, «MOLECULAR BIOLOGY OF THE CELL», 2011, 22, pp. 2946 - 2956 [articolo]
Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C;
Mongiorgi S; Parisi S; Bosi C; Manzoli L; Martinelli G; Cocco L;
Baccarani M, AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES, in: HAEMATOLOGICA, 2011, 96, pp. 163 - 163 (atti di: 43° Congress of the Italian Society of Hematology, NAPOLI, 16-19 OTTOBRE 2011) [Contributo in Atti di convegno]
C. Fill; C. Finelli; M. Gobbi; G. Martinelli; I. Iacobucci; E. Ottaviani; L. Cocco; F. Matilde; A. Candoni; E. Simeone; M. Miglino; F. Lauria; M. Bocchia; M. Defina; C. Clissa; F. Lanza; P. Spedini; C. Skert; C. Bergonzi; M. Malagola; A. Peli; A. Turra; F. Cattina; C. Colombi; D. Russo, Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study, in: Abstracts of the 11th International Symposium on Myelodysplastic Syndromes (MDS), «LEUKEMIA RESEARCH», 2011, 35, pp. S84 - S85 (atti di: 11th International Symposium on Myelodysplastic Syndromes (MDS), EDINBURGH, 18-21 MAGGIO 2011) [atti di convegno-abstract]
M.Y. Follo; S. Mongiorgi; C. Clissa; C. Filì; C. Colombi; M. Baccarani; G. Martinelli; M. Gobbi; L. Manzoli; D. Russo; C. Finelli; L. Cocco, Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients, in: LEUKEMIA RESEARCH, 2011, SUPPLEMENT 1, MAY 2011, pp. S94 - S94 (atti di: 11th International Symposium on Myelodysplastic Syndromes (MDS), EDINBURGH, 18-21 MAGGIO 2011) [Contributo in Atti di convegno]
Follo MY;Mongiorgi S; Clissa C; Baccarani M; Paolini S;
Martinelli G; Manzoli L; Finelli C; Cocco L, EFFECT OF LENALIDOMIDE ON INOSITIDE-DEPENDENT SIGNAL TRANSDUCTION PATHWAYS, in: HAEMATOLOGICA, 2011, 96, pp. 158 - 158 (atti di: 43° Congress of the Italian Society of Hematology, NAPOLI, 16-19 OTTOBRE 2011) [Contributo in Atti di convegno]
Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco, Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients, in: BLOOD, 2011, 118, pp. 4635 - 4635 (atti di: 53th ASH ANNUAL MEETING AND EXPOSITION, SAN DIEGO, CA, 10-13 DECEMBER 2011) [Contributo in Atti di convegno]
Matilde Y. Follo; Sara Mongiorgi; Cristina Clissa; Costanza Bosi; Michele Baccarani; Giovanni Martinelli; Patrizia Santi; Giulia Ramazzotti; Anna Maria Billi; Lucia Manzoli; Carlo Finelli; Lucio Cocco, Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients, in: Italian Journal of Anatomy and Embriology, 2011, 116, pp. 74 - 74 (atti di: 65° Meeting of the Italian Society of Anatomy and Histology, Padova, 27-29 September 2011) [Contributo in Atti di convegno]
